Benzinga | Nov 3, 2021 09:16AM EDT

Harvard Bioscience Q3 EPS $0.06, Inline, Sales $29.66M Beat $27.91M Estimate

Harvard Bioscience (NASDAQ:HBIO) reported quarterly earnings of $0.06 per share which met the analyst consensus estimate. This is a 50 percent increase over earnings of $0.04 per share from the same period last year. The company reported quarterly sales of $29.66 million which beat the analyst consensus estimate of $27.91 million by 6.28 percent. This is a 23.41 percent increase over sales of $24.04 million the same period last year.